Stem cell therapy for prevention of radiation-induced salivary gland toxicity

Share :
Published: 7 Oct 2013
Views: 5362
Rating:
Save
Dr Rob Coppes - University of Groningen, Netherlands

Dr Rob Coppes talks to ecancer at the 2013 European Cancer Congress in Amsterdam about preventing the toxicity of the salivary glands in patients with head and neck cancer.

Dr Coppes highlights the importance of preventing this issue as it can cause numerous complications and greatly affect the patient's quality of life.

Related Videos

Multiple Myeloma: evolving paradigm - Panel Discussion

Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr Siddharth Nanda AIIMS, Dr Avinash Tiwari, Dr Rudra Pratap, Dr Siddharth Turkar
Multiple Myeloma: evolving paradigm - Panel Discussion ( Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr Siddharth Nanda AIIMS, Dr Avinash Tiwari, Dr Rudra Pratap, Dr Siddharth Turkar )
10 Oct 2024

Breastfeeding after breast cancer is safe

Dr Eva Blondeaux - Ospedale San Martino, Genova, Italy
Breastfeeding after breast cancer is safe ( Dr Eva Blondeaux - Ospedale San Martino, Genova, Italy )
14 Sep 2024

ASCO 2024: Lung cancer highlights

Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom
ASCO 2024: Lung cancer highlights ( Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas Girard and Dr Anna Minchom )
26 Jun 2024

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy ( Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines )
12 Jun 2024

Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer

Prof Jens Hoeppner - University of Bielefeld, Bielefeld, Germany
Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer ( Prof Jens Hoeppner - University of Bielefeld, Bielefeld, Germany )
3 Jun 2024

Transoral surgery and neck dissection with deintensified risk-based post-operative management increases efficacy in oropharynx cancer

Dr Barbara Burtness - Yale School of Medicine, New Haven, USA
Transoral surgery and neck dissection with deintensified risk-based post-operative management increases efficacy in oropharynx cancer ( Dr Barbara Burtness - Yale School of Medicine, New Haven, USA )
3 Jun 2024

Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-positive mCRPC ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
2 Jun 2024

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK
Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )
17 Feb 2023

Stereotactic body radiotherapy compared with surgery for localised prostate cancer

Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK
Stereotactic body radiotherapy compared with surgery for localised prostate cancer ( Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK )
16 Feb 2023